George A. Scangos

2014 - Biogen

In 2014, George A. Scangos earned a total compensation of $18.6M as Chief Executive Officer at Biogen, a 24% increase compared to previous year.

Compensation breakdown

Change in Pension Value and Nonqualified Deferred Compensation Earnings$86,634
Non-Equity Incentive Plan$4,047,313
Salary$1,375,000
Stock Awards$12,120,939
Other$1,001,483
Total$18,631,369

Scangos received $12.1M in stock awards, accounting for 65% of the total pay in 2014.

Scangos also received $86.6K of change in pension value and nonqualified deferred compensation earnings, $4M in non-equity incentive plan, $1.4M in salary and $1M in other compensation.

Rankings

In 2014, George A. Scangos' compensation ranked 143rd out of 13,032 executives tracked by ExecPay. In other words, Scangos earned more than 98.9% of executives.

ClassificationRankingPercentile
All
143
out of 13,032
99th
Division
Manufacturing
55
out of 4,967
99th
Major group
Chemicals And Allied Products
23
out of 1,690
99th
Industry group
Drugs
20
out of 1,369
99th
Industry
Biological Products, Except Diagnostic Substances
2
out of 241
99th
Source: SEC filing on April 15, 2016.

Scangos' colleagues

We found seven more compensation records of executives who worked with George A. Scangos at Biogen in 2014.

2014

Alfred Sandrock

Biogen

Chief Medical Officer

2014

Adriana Karaboutis

Biogen

EVP, Technology and Business Solutions

2014

Adam Koppel

Biogen

SVP, Chief Strategy Officer

2014

Douglas Williams

Biogen

Former EVP, Research and Development

2014

Paul Clancy

Biogen

Chief Financial Officer

2014

John Cox

Biogen

EVP, Pharmaceutical Operations and Technology

2014

Stuart Kingsley

Biogen

Former EVP, Global Operations

You may also like